MyFinsight
Home
Blog
About
Current portion of notes
receivable
$197K
(-1.50%↓ Y/Y)
Inventory
$62K
(-87.24%↓ Y/Y)
Prepaid expenses and
other current assets
$51K
(-70.18%↓ Y/Y)
Cash
$10K
Other intangible
assets, net
$16,425K
(-6.49%↓ Y/Y)
Total current assets
$320K
(-78.39%↓ Y/Y)
Total assets
$16,745K
(-12.15%↓ Y/Y)
Total liabilities and
stockholders equity
$16,745K
(-12.15%↓ Y/Y)
Total stockholders
equity
$14,012K
(289.86%↑ Y/Y)
Total liabilities
$2,733K
(-89.66%↓ Y/Y)
Total stockholders
equity of the company
$10,766K
(204.11%↑ Y/Y)
Non-controlling interest in
subsidiaries
$3,246K
(9.63%↑ Y/Y)
Total current
liabilities
$2,045K
(-91.17%↓ Y/Y)
Deferred tax liability,
net
$688K
(-78.95%↓ Y/Y)
Accumulated deficit
-$52,492K
(1.48%↑ Y/Y)
Additional paid-in capital
$63,150K
(47.31%↑ Y/Y)
Due to related party
$1,330K
Accounts payable
$467K
(-15.70%↓ Y/Y)
Accrued expenses
$248K
(-6.77%↓ Y/Y)
Common stock, 0.001 par
value 4,000,000,000...
$108K
(800.00%↑ Y/Y)
Back
Back
Balance Sheet
IMPACT BIOMEDICAL INC. (IBO)
IMPACT BIOMEDICAL INC. (IBO)
source: myfinsight.com